Ignite Creation Date:
2025-12-24 @ 10:19 PM
Ignite Modification Date:
2026-02-25 @ 6:33 PM
Study NCT ID:
NCT00948935
Status:
COMPLETED
Last Update Posted:
2020-03-11
First Post:
2009-05-15
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Gemcitabine, Irinotecan and Panitumumab in Patients With Advanced and Metastatic Biliary Tract Adenocarcinoma
Sponsor:
Abramson Cancer Center at Penn Medicine
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-04
Start Date Type:
ACTUAL
Primary Completion Date:
2014-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-09-26
Completion Date Type:
ACTUAL
First Submit Date:
2009-05-15
First Submit QC Date:
None
Study First Post Date:
2009-07-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-04-16
Results First Submit QC Date:
None
Results First Post Date:
2019-06-18
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-03-09
Last Update Post Date:
2020-03-11
Last Update Post Date Type:
ACTUAL